Evidence map›Paper›PMID 29348139›Full record

ArticleRNA (New York, N.Y.)2018

Dissecting the functions of SMG5, SMG7, and PNRC2 in nonsense-mediated mRNA decay of human cells.

Pamela Nicholson, Asimina Gkratsou, Christoph Josi, Martino Colombo, Oliver Mühlemann

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pamela Nicholson *Department of Chemistry and Biochemistry, University of Bern, Bern 3012, Switzerland.
Asimina Gkratsou *Department of Chemistry and Biochemistry, University of Bern, Bern 3012, Switzerland.
Christoph JosiDepartment of Chemistry and Biochemistry, University of Bern, Bern 3012, Switzerland.
Martino ColomboDepartment of Chemistry and Biochemistry, University of Bern, Bern 3012, Switzerland.
Oliver MühlemannDepartment of Chemistry and Biochemistry, University of Bern, Bern 3012, Switzerland.ORCID 0000-0003-0657-1368
University of Bern · CH

Funding

European Research Council 207419
6 · The paper itself

Abstract

The term "nonsense-mediated mRNA decay" (NMD) originally described the degradation of mRNAs with premature translation-termination codons (PTCs), but its meaning has recently been extended to be a translation-dependent post-transcriptional regulator of gene expression affecting 3%-10% of all mRNAs. The degradation of NMD target mRNAs involves both exonucleolytic and endonucleolytic pathways in mammalian cells. While the latter is mediated by the endonuclease SMG6, the former pathway has been reported to require a complex of SMG5-SMG7 or SMG5-PNRC2 binding to UPF1. However, the existence, dominance, and mechanistic details of these exonucleolytic pathways are divisive. Therefore, we have investigated the possible exonucleolytic modes of mRNA decay in NMD by examining the roles of UPF1, SMG5, SMG7, and PNRC2 using a combination of functional assays and interaction mapping. Confirming previous work, we detected an interaction between SMG5 and SMG7 and also a functional need for this complex in NMD. In contrast, we found no evidence for the existence of a physical or functional interaction between SMG5 and PNRC2. Instead, we show that UPF1 interacts with PNRC2 and that it triggers 5'-3' exonucleolytic decay of reporter transcripts in tethering assays. PNRC2 interacts mainly with decapping factors and its knockdown does not affect the RNA levels of NMD reporters. We conclude that PNRC2 is probably an important mRNA decapping factor but that it does not appear to be required for NMD.

Indexed as

Carrier ProteinsCell Line, TumorCodon, NonsenseGene Expression RegulationHeLa CellsHumansNonsense Mediated mRNA DecayProtein BindingReceptors, Cytoplasmic and NuclearRNA HelicasesRNA InterferenceRNA, MessengerRNA, Small InterferingTrans-ActivatorsTwo-Hybrid System TechniquesCarrier ProteinsCodon, NonsensePNRC2 protein, humanReceptors, Cytoplasmic and NuclearRNA HelicasesRNA, MessengerRNA, Small InterferingSMG5 protein, humanSMG7 protein, humanTrans-ActivatorsUPF1 protein, humanmRNA decappingmRNA turnoverNMDPNRC2 tethered function assaySMG5SMG7UPF1

Identifiers

PMID29348139
PMCPMC5855955
OpenAlexW2789817396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.